The  (MSAA) is pleased to provide vital services and resources to individuals affected by MS, their families, and care ...

People living with an autoimmune disease are nearly twice as likely to suffer from mood problems like depression, anxiety or ...

Patients with relapsed/refractory myeloma from lower socioeconomic groups face worse quality of life, even in countries with universal health care, according to Francesco Sparano, MSc, of the ...

The risk of mood disorders is 87% to 97% higher in people suffering from rheumatoid arthritis, inflammatory bowel disease, ...

Multiple Sclerosis, the most common neurological disorder in young adults, with symptoms usually occurring between the ages of 20 and 40 years. The rising prevalence of multiple sclerosis (MS) is ...

The global autoimmune disease therapeutics market is anticipated to expand steadily from 2025 to 2035, driven by increasing cases of rheumatoid arthritis, psoriasis, and inflammatory bowel disease.

Introduction A major driver of the global autologous cell therapy market is the rising demand for personalized and precision-based medical trea ...

The auto-injectors market is forecast to reach a value of USD 5.71 billion in 2025 and is expected to expand to USD 23.31 billion by 2035, growing at a steady compound annualgrowth rate of 8.2% over ...

ABOUT 5.7 MILLION men could have an autoimmune disease, according to a 2024 study published in the Journal of Clinical Investigation. The authors believe it’s the first to estimate the prevalence of ...

Researchers say there may be an association between attention deficit hyperactivity disorder (ADHD) and irritable bowel ...

Historically, optic nerve involvement has been excluded from MS diagnostic criteria, but its inclusion in the new iteration is expected to significantly accelerate time to diagnosis.